Founded in 2012, MyTomorrow is a health technology company dedicated to facilitating Early Access Programs (EAPs) for medicines that are still in development. The company has built a comprehensive global platform that connects patients with unmet medical needs and their doctors to biopharmaceutical companies, helping to navigate the complex regulatory, logistical, and administrative challenges of accessing pre-approval treatments. MyTomorrow's mission is to ensure that when a conventional treatment is not an option, patients can learn about and try to access investigational drugs as quickly and fairly as possible.

Founded in

United Kingdom